U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. 2022 FDA Digital Transformation Symposium - 12/05/2022
  1. FDA Meetings, Conferences and Workshops

Virtual | Virtual

Event Title
2022 FDA Digital Transformation Symposium
December 5 - 7, 2022

Date:
December 5 - 7, 2022
Day1:
Mon, Dec 05 9:00 a.m. - 03:00 p.m. ET
Day2:
Tue, Dec 06 9:00 a.m. - 04:30 p.m. ET
Day3:
Wed, Dec 07 9:00 a.m. - 03:30 p.m. ET
Sponsored By:
Sponsor
Office of Digital Transformation
Image
2022 Digital Transformation Symposium. Hosted by FDA's Office of Digital Transformation.

 

2022 FDA Virtual Digital Transformation Symposium

The first annual digital transformation symposium hosted by the FDA's Office of Digital Transformation (ODT)

Event Dates
Day 1: Monday, December 5, 2022, 9:00 AM - 3:00 PM (ET) 
Keynote: Holistic Modernization - Vid Desai, FDA Chief Information Officer Fireside Chat - The Direction of Information Technology in FDA - Dr. Califf, FDA Commissioner & Dr. Janet Woodcock, FDA Principal Deputy Commissioner

Day 2: Tuesday, December 6, 2022, 9:00 AM - 4:30 PM (ET)
Keynote: Connecting the Dots: Building a Data and Talent Ecosystem - Ram Iyer, FDA Chief Data Officer
Keynote: The Art and Science of Racing - Robert Megennis, 1:00 PM - 1:45 PM (ET)

Day 3: Wednesday, December 7, 2022, 9:00 AM - 3:30 PM (ET)
Keynote by Gartner Research: Emerging Technology Trends - David Groombridge, Distinguished VP Analyst, IT Leaders & Tech

Registration Information - REGISTER HERE
Registration for the event is now open! (Attendees will register for virtual attendance only)

About the Symposium:

  • Learn more about the FDA’s IT vision and strategic direction.

  • Hear from FDA leaders on how the agency is leveraging advances in data, cloud, user experience (UX), cybersecurity, IT governance, and operational/organizational excellence to deliver on its mission to protect public health.

  • Participate and engage in information sharing with industry, tech, and vendor communities on how the FDA can continue to collaborate with stakeholder constituents to drive innovation, key initiatives, and achieve successful technology solutions.  

 

COVID-19 Information for FDA and panelists attending in person: Please review the CDC Community Level Website for recommended prevention guidance for Montgomery County, Maryland. If the community level is high, we will follow CDC guidelines that all attendees wear a high-quality mask or respirator if attending in-person.

 

 

 

 


        Meeting Agenda
        Program Summaries

 

For questions, contact ODT-Communications@fda.hhs.gov.

 

Back to Top